Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 1, 2002

Circulation. 2002
Published online before print July 1, 2002, doi: 10.1161/01.CIR.0000023526.45800.8E
A more recent version of this article appeared on July 30, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/5/613    most recent
01.CIR.0000023526.45800.8Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, Y.
Right arrow Articles by Nakaya, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Matsumoto, Y.
Right arrow Articles by Nakaya, H.

Submitted on April 8, 2002
Revised on May 7, 2002
Accepted on May 7, 2002

Long-Term Endothelin A Receptor Blockade Inhibits Electrical Remodeling in Cardiomyopathic Hamsters

Yasunori Matsumoto MD, PhD, Hajime Aihara MS, Rikako Yamauchi-Kohno PhD, Yoshie Reien BS, Takehiko Ogura MD, Hideo Yabana PhD, Yoshiaki Masuda MD, PhD, Toshiaki Sato MD, PhD, Issei Komuro MD, PhD, and Haruaki Nakaya MD, PhD*

From the Departments of Pharmacology (Y. Matsumoto, Y.R., T.O., T.S., H.N.) and Cardiovascular Science and Medicine (Y. Matsumoto, Y. Masuda, I.K.), Chiba University Graduate School of Medicine, Chiba, Japan; and Discovery Research Laboratory (H.A., R.Y.-K., H.Y.), Tanabe Seiyaku Co Ltd, Saitama, Japan.

* To whom correspondence should be addressed. E-mail: nakaya{at}med.m.chiba-u.ac.jp.

Background—The endothelin (ET) system is activated in failing hearts. Congestive heart failure frequently is associated with ventricular arrhythmias, which may result from electrical remodeling such as changes of ionic current density and heterogeneous action potential prolongation. We examined the effects of long-term ETA receptor blockade on the electrophysiological properties of ventricular cells, the surface ECG, and the survival in BIO 14.6 cardiomyopathic hamsters.

Methods and Results—Membrane currents and action potentials were recorded from left ventricular cells isolated from normal F1ß hamsters and cardiomyopathic BIO 14.6 hamsters untreated and chronically treated with TA-0201, an ETA receptor antagonist. In ventricular cells of untreated BIO 14.6 hamsters, the action potential duration was prolonged and the densities of the L-type Ca2+ current (ICa,L), the transient outward current (Ito), the delayed rectifier K+ current (IK), and the inward rectifier K+ current (IK1) were decreased compared with those of F1ß hamsters. Long-term treatment with the ETA receptor antagonist significantly attenuated action potential duration prolongation and reduction of Ito, IK, and ICa,L in BIO 14.6 ventricular cells. Long-term ETA receptor blockade prevented the QT prolongation and ventricular arrhythmias and improved the survival rate in the cardiomyopathic hamsters.

Conclusions—Long-term treatment with an ETA antagonist inhibits electrical remodeling such as downregulation of K+ and Ca2+ currents, action potential prolongation, and the increased QT interval and thereby suppresses ventricular arrhythmias in cardiomyopathic hearts. ETA receptor blockade may provide a new strategy for the prevention of ventricular arrhythmias associated with heart failure.


Key words: endothelin • ion channels • cardiomyopathy • electrophysiology




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, C.-C. Chen, M.-S. Lin, and N.-C. Chang
Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1871 - H1879.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, M.-S. Lin, T.-F. Chou, C.-H. Tsai, and N.-C. Chang
Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H220 - H227.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Nattel
Defining "Culprit Mechanisms" in Arrhythmogenic Cardiac Remodeling
Circ. Res., June 11, 2004; 94(11): 1403 - 1405.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Wasson, H. K. Reddy, and M. L. Dohrmann
Current Perspectives of Electrical Remodeling and Its Therapeutic Implications
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144.
[Abstract] [PDF]


Home page
CirculationHome page
Z. Lako-Futo, I. Szokodi, B. Sarman, G. Foldes, H. Tokola, M. Ilves, H. Leskinen, O. Vuolteenaho, R. Skoumal, R. deChatel, et al.
Evidence for a Functional Role of Angiotensin II Type 2 Receptor in the Cardiac Hypertrophic Process In Vivo in the Rat Heart
Circulation, November 11, 2003; 108(19): 2414 - 2422.
[Abstract] [Full Text] [PDF]